VJHemOnc is committed to improving our service to you

ASCO 2019 | The clinical application of MRD testing in AML

VJHemOnc is committed to improving our service to you

Michael Heuser

Here, Michael Heuser, MD, of Hannover Medical School, Hanover, Germany, gives a background on the clinical application of measurable residual disease (MRD) testing for acute myeloid leukemia (AML). This interview was recorded at the American Society of Oncology (ASCO) 2019 Annual Meeting, held in Chicago, IL.

Share this video  
Similar topics

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter